Abhishek  Jain net worth and biography

Abhishek Jain Biography and Net Worth

CFO of CareDx

Abhishek Jain is CareDx’s Chief Financial Officer. Abhishek joined CareDx as Vice President, Corporate Controller in August 2021. Prior to joining the Company, he spent the last 20 years at Agilent Technologies, Inc., a global leader in the life sciences, diagnostics and applied chemical markets, in a series of finance and customer-facing roles of progressing responsibility. In his last role at Agilent as an Associate Vice President II, Controller-Sales and Marketing, he drove above market growth for a $5B business. He has extensive knowledge in driving channel strategy, expanding margins, scaling operations, and leading global teams. Mr. Jain is a member of the Institute of Chartered Accountants of India.

What is Abhishek Jain's net worth?

The estimated net worth of Abhishek Jain is at least $5.95 million as of April 7th, 2025. Mr. Jain owns 337,418 shares of CareDx stock worth more than $5,945,305 as of April 20th. This net worth approximation does not reflect any other investments that Mr. Jain may own. Additionally, Mr. Jain receives an annual salary of $425,580.00 as CFO at CareDx. Learn More about Abhishek Jain's net worth.

How old is Abhishek Jain?

Mr. Jain is currently 47 years old. There are 3 older executives and no younger executives at CareDx. The oldest executive at CareDx is Dr. Peter Maag Ph.D., Executive Director, who is 57 years old. Learn More on Abhishek Jain's age.

What is Abhishek Jain's salary?

As the CFO of CareDx, Inc, Mr. Jain earns $425,580.00 per year. The highest earning executive at CareDx is Mr. Alexander L. Johnson, President of Patient & Testing Services, who commands a salary of $547,430.00 per year. Learn More on Abhishek Jain's salary.

How do I contact Abhishek Jain?

The corporate mailing address for Mr. Jain and other CareDx executives is 1 TOWER PLACE 9TH FLOOR, SOUTH SAN FRANCISCO CA, 94080. CareDx can also be reached via phone at (415) 287-2300 and via email at caroline.corner@westwicke.com. Learn More on Abhishek Jain's contact information.

Has Abhishek Jain been buying or selling shares of CareDx?

During the past quarter, Abhishek Jain has sold $4,695.80 of CareDx stock. Most recently, Abhishek Jain sold 265 shares of the business's stock in a transaction on Monday, April 7th. The shares were sold at an average price of $17.72, for a transaction totalling $4,695.80. Following the completion of the sale, the chief financial officer now directly owns 337,418 shares of the company's stock, valued at $5,979,046.96. Learn More on Abhishek Jain's trading history.

Who are CareDx's active insiders?

CareDx's insider roster includes Paul Adler (CEO), George Bickerstaff, III (Director), Ankur Dhingra (CFO), Michael Goldberg (Director), William Hagstrom (Director), Abhishek Jain (CFO), Sasha King (CMO), Peter Maag (Insider), Reginald Seeto (Insider), Ralph Snyderman (Director), and Thomas Thomas (Director). Learn More on CareDx's active insiders.

Are insiders buying or selling shares of CareDx?

In the last twelve months, insiders at the sold shares 5 times. They sold a total of 96,605 shares worth more than $3,155,110.99. The most recent insider tranaction occured on April, 7th when CFO Abhishek Jain sold 265 shares worth more than $4,695.80. Insiders at CareDx own 4.9% of the company. Learn More about insider trades at CareDx.

Information on this page was last updated on 4/7/2025.

Abhishek Jain Insider Trading History at CareDx

See Full Table

Abhishek Jain Buying and Selling Activity at CareDx

This chart shows Abhishek Jain's buying and selling at CareDx by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$4.70ksoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$4k-$2k$0$2k$4kTotal Insider BuyingTotal Insider Selling

CareDx Company Overview

CareDx logo
CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
Read More

Today's Range

Now: $17.62
Low: $17.56
High: $18.24

50 Day Range

MA: $19.73
Low: $16.96
High: $24.84

2 Week Range

Now: $17.62
Low: $7.42
High: $34.84

Volume

537,147 shs

Average Volume

853,578 shs

Market Capitalization

$976.61 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.18